2025³â 08¿ù 08ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92587°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

GS25 ¡®»ý°úÀÏ ½º¹«µð¡¯ ¿î¿µÁ¡ ±âÁØ Àüü ÆÇ¸Å·® 3À§

2030 ¼¼´ë°¡ °í°´ 69.5%
GS25°¡ ¾÷°è ÃÖÃÊ·Î ¼±º¸ÀÎ »ý°úÀÏ ½º¹«µð Àü¿ë ±â±â GS¸®Å×ÀÏÀÌ ¿î¿µÇÏ´Â ÆíÀÇÁ¡ GS25°¡ º»°ÝÀûÀÎ ¹«´õÀ§¸¦ ¸Â¾Æ ÃÖ±Ù 2ÁÖ°£(6/23~7/6) ‘»ý°úÀÏ ½º¹«µð’ ¿î¿µ Á¡Æ÷ 20¿© °÷À» ´ë»óÀ¸·Î ÆÇ¸Å µ¥ÀÌÅ͸¦ ºÐ¼®ÇÑ °á°ú »ý°úÀÏ ½º¹«µð°¡ ‘Ä«Æä25 ¾Æ¸Þ¸®Ä«³ë’, ‘ÄÅ ¾óÀ½’¿¡ À̾î Àüü ÆÇ¸Å·® 3À§(´ã¹è Á¦¿Ü)¿¡ µî±ØÇÑ °ÍÀ¸·Î ºÐ¼®µÆ´Ù. GS25´Â Áö³­ÇØ 12¿ù ÆíÀÇÁ¡ ¾÷°è ÃÖÃÊ·Î Á÷¿µÁ¡ ÇѰ÷À» ÅëÇØ Áï¼® »ý°úÀÏ ½º¹«µð¸¦ ¼±º¸¿´´Ù. ÃֽŠ¸Ô°Å¸® Æ®·»µå¸¦ ¼±Á¡ÇϰíÀÚ ÆíÀÇÁ¡ Ư¼º¿¡ ¸Â´Â Àü¿ë ±â±â ...
Middle East¡¯s Leading Venue Manager ASM Global Named Operat... (2023-09-20)
¡®ÀÌÅ»¸®¾Æ ÆÔ¡¯ ÃÖº´¹ÎX¾È³ª, ÃÖº´¹Î ¾î¸Ó´Ï¿Í º£³×Ä¡¾Æ ¿©Çà (2024-02-19)
Results From Galderma¡¯s Phase IIIb Trials Demonstrate Rapid... (2023-11-30)
»ê¾÷±âÀÚÀç ³¹°³ ±¸¸Å °¡´É ³×À̹ö ½º¸¶Æ® ½ºÅä¾î ·ÐĪ (2023-11-03)
ºñÅõ¿£, XOOX Korea ¹ýÀÎ ¼³¸³ (2024-02-14)
¸¸°³ÀÇ·¹½ÃÇÇ, Àλï Ȱ¿ëÇÑ ¡®»ï»ïÇÑ ·¹½ÃÇÇ °ø¸ðÀü¡¯ (2023-09-10)
º£Æ®³²¿ì¸®ÀºÇà, Æß¹ðÅ·°ú ±â¾÷ ERP ¿¬µ¿... ±ÝÀ¶ ¼­ºñ½º Çõ½Å (2024-07-15)
LG¡¯s ALL NEW Styler Takes the Spotlight at Taipei Fashion W... (2024-11-22)
Three Leading Risk Companies Unite Under New G2 Risk Solutio... (2024-01-13)
'µ¶¹ÚÅõ¾î¡¯ ±è´ëÈñ, ½ÄŽ Æø¹ß½ÃŰ´Â ±èÁØÈ£ ÇâÇØ ¡®°æ°í¡¯ (2024-01-13)
¡®°íµù¾öºü¡¯ ¡°ÀÌ·¸°Ô ¹«Ã¥ÀÓÇÑ »ç¶÷ óÀ½ ºÁ¡± ºÐ³ëÇÑ »ç¿¬? (2024-05-22)
'µ¶¹ÚÅõ¾î¡¯ ±èÁØÈ£, ¡°Áö¹ÎÀÌ ¾îµø¾î~¡± (2024-03-02)
À̺êÀÚ¸® ½½¸³¾Ø½½¸³ ȸ±âÁ¡ »õ ´ÜÀå (2023-07-08)
¿ì¼ö±â¼ú º¸À¯ ³ó»ê¾÷ü À°¼º ÇÁ·Î±×·¥ ¡®¾Ö±×¸®Ç»Ã³¡¯ (2023-12-12)
Access Advance Announces Major Additions to its HEVC and VVC... (2023-12-12)
SEKISUI CHEMICAL: Filing of Lawsuit Seeking Injunction and D... (2024-11-17)
H.I.G. Capital Expands Middle East Presence with New Dubai O... (2024-01-30)
Brandnew Lab to Host Symposium on New Clinic-Use Ampoule ¡®N... (2024-08-01)
³ëµ¿ºÎ ºÎÁ¤¼ö±Þ ¿¹¹æ ¹× ´ëÀÀ ¸Å´º¾ó (2024-07-05)
ÇÑÈ­, ¹Ì±¹ ÄÚ³×Æ¼ÄÆ¿¡¼­ ¡®Ç»Ã³ ¿£Áø µ¥ÀÌ¡¯ °³ÃÖ (2024-07-05)
Black Hat Asia 2024: Full Schedule Programming for Singapore... (2024-04-15)
2024³â, ´ë³»¿Ü ºÒÈ®½Ç¼º°ú °í±Ý¸®·Î ±ÝÀ¶»ê¾÷ ¼ÒÆø ¼ºÀå (2023-11-05)
Å©¸°ÅäÇǾÆ, °Ü¿ï¿Ê Àå±â º¸°ü ¡®ÀÇ·ùº¸°ü ¼­ºñ½º¡¯ Á¦°ø (2024-03-09)
¸ÂÃãÇü »ç³» ½º³¼¹Ù ¡®¿ÀÇǽº °£½Ä¡¯ ¼­ºñ½º Ãâ½Ã (2024-05-29)
Çѱ¹¼öÀÚ¿ø°ø»ç, Çʸ®ÇÉ ½Åµµ½Ã µî ¹° ¹®Á¦ ÇØ°á (2024-07-22)
       [ÀÌÀü][1]....[677][678][679][680][681][682][683][684][685]...[3704][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..